Platelet-derived microparticles in patients with high cardiovascular risk and subclinical atherosclerosis

Thrombosis and Haemostasis

Volumn 114, Issue 6, 2015, Pages 1099-

  Wojta, Johann ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; HUMAN; HYPERCHOLESTEROLEMIA; NOTE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RISK FACTOR; CARDIOVASCULAR DISEASE; MEMBRANE MICROPARTICLE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; HUMANS; RISK FACTORS;

EID: 84948761403     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-09-0720     Document Type: Note

References (4)

1. Burnier L, Fontana P, Kwak BR, et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
2. Suades R, Padro T, Alonos R, et al. High levels of TSP1+/CD142+ platelet-derived microparticles characterize young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost 2015; 114: 1310-1321.
3. Lacroix R, Judicone C, Mooberry M, et al.; The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; Epub ahead of print.
4. Shantsila E, Montoro-García S, Gallego P, et al. Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemost 2014; 111: 1009-1014.